McKesson Corporation MCK

866.64 (2.72) (0.31%) as of 25 Sep
Market cap
$101.8B
P/E
23.1×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

McKesson Corporation (MCK) Revenue growth

McKesson Corporation's revenue growth over the twelve months to 30 June 2026 was 8.84%, down 3.5 percentage points from fiscal 2026 (12.4%). Over the past ten years it has ranged from 2.86% (fiscal 2019) to 30.3% (fiscal 2015); the current reading is higher than 83% of that period. That is below the Medical Distribution industry median of 11.5% and above the Healthcare sector median of 8.26%.

Revenue growth, annual

Annual

Period Revenue growth Change (points)
FY2026 12.4% (3.86)
FY2025 16.2% 4.57
FY2024 11.7% 6.82
FY2023 4.83% (5.97)
FY2022 10.8% 7.69
FY2021 3.11% (4.70)
FY2020 7.81% 4.95
FY2019 2.86% (2.09)
FY2018 4.95% 0.94
FY2017 4.01% (2.60)

Quarterly

Period Revenue growth Change (points)
Jun 2026 7.72% 1.70
Mar 2026 6.02% (5.38)
Dec 2025 11.4% 1.26
Sep 2025 10.1% (13.25)
42 more quarters

Against its own ten years

Low 2.86% High 30.3%
Ten-year median 7.21%
Current reading's percentile 83

Revenue growth against peers

Company Revenue growth
ACH Accendra Health, Inc. compare 247.0%
AHG Akso Health Group Sponsored ADR compare 208.4%
COSM Cosmos Health Inc. compare 33.8%
FOCL FocalTherics compare 29.5%
CAH Cardinal Health, Inc. compare 14.2%
MCK McKesson Corporation 8.84%
HSIC Henry Schein, Inc. compare 6.49%
COR Cencora, Inc. compare 5.09%
YI 111, Inc. Sponsored ADR compare −16.2%
Medical Distribution industry median 11.5%
Healthcare sector median 8.26%
Market median 7.41%

What Revenue growth is

Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.

(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|

The full definition of Revenue growth →

More on MCK